Diabetes Education and News

Jordan Wright on the exocrine pancreas, Lisa Smeehuijzen on circulating monocytes for individuals...
Jordan Wright on the exocrine pancreas, Lisa Smeehuijzen on circulating monocytes for individuals...

Jordan Wright on the exocrine pancreas, Lisa Smeehuijzen on circulating monocytes for individuals...

Jordan Wright on the exocrine pancreas, Lisa Smeehuijzen on circulating monocytes for individuals...Welcome to the July 2024 episode of DiabetesBio—the American Diabetes Association’s podcast for its flagship research publication, Diabetes (https://diabetesjournals.org/diabetes) . In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the July 2024 issue of Diabetes.  4:31: Darleen and Kirk are joined by Dr. Jordan J. Wright (https://medicine.vumc.org/department-directory/Jordan-J-Wright) , first author of the Paper of the Month, entitled “Exocrine Pancreas in Type 1 and Type 2 Diabetes: Different Patterns of Fibrosis, Metaplasia, Angiopathy, and Adiposity.” This article is an editor-selected feature article and is freely accessible at https://doi.org/10.2337/db23-0009.  17:23: Kirk and Darleen then chat with Dr. Lisa Smeehuijzen (https://www.wur.nl/en/persons/lisa-smeehuijzen.htm) , first author of the article “Immunometabolic Signatures of Circulating Monocytes in Humans With Obesity and Insulin Resistance.” This article is an editor-selected feature article and is freely accessible at https://doi.org/10.2337/db23-0970. 20:26: In a very special Sweet Talk segment, Kevin is joined by cohosts Darleen and Kirk for an interview with Dr. Rury R. Holman (https://www.rdm.ox.ac.uk/people/rury-holman) , the winner of the 2024 Banting Medal for Scientific Achievement (https://professional.diabetes.org/awards/banting-medal-scientific-achievement-rury-r-holman) . More details about this award can be found at https://professional.diabetes.org/awards/banting-medal-scientific-achievement-award.      To learn more about Diabetes and DiabetesBio, please visit diabetesjournals.org/diabetes (https://diabetesjournals.org/diabetes) . Thank you for listening, and don’t forget to smash that “follow” button!
Wrap-up of the 84th Scientific Sessions, David Sacks on optimal use of point-of-care HbA1c in cli...
Wrap-up of the 84th Scientific Sessions, David Sacks on optimal use of point-of-care HbA1c in cli...

Wrap-up of the 84th Scientific Sessions, David Sacks on optimal use of point-of-care HbA1c in cli...

Wrap-up of the 84th Scientific Sessions, David Sacks on optimal use of point-of-care HbA1c in cli...Welcome to episode no. 21 (July 2024) of Diabetes Care “On Air”—a new and different way to bring the research published in Diabetes Care (https://diabetesjournals.org/care) to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the July 2024 issue of Diabetes Care.  0:42 Mike and Alice open the show by talking about the spectacularly successful 84th Scientific Sessions (https://professional.diabetes.org/scientific-sessions) , which took place 21–24 June in Orlando, FL. Mike shares his enjoyment of various symposia on clinical trial results, scientific award lectures, and even the basic science sessions. Alice, chair of the planning committee for the Scientific Sessions, thanks her fellow members on the planning committee and describes her number one problem with the event: deciding which session to attend!  3:56: Alice begins the interview portion of the show by hosting Dr. David Sacks (https://www.cc.nih.gov/meet-our-doctors/dsacks.html) , lead author on the review “Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use.” This review is an editor-selected feature article appearing in the July 2024 issue and is openly accessible at https://doi.org/10.2337/dci23-0040.  18:53: Mike talks to Dr. Coco M. Fuhri Snethlage (https://www.amsterdamumc.org/en/research/researchers/coco-fuhri-snethlage.htm) , first author of “Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.” This study is also an editor-selected feature article in the July 2024 issue and is openly accessible at https://doi.org/10.2337/dc23-0776.  28:47: In the “Diabetes Care Rapid Exchange,” Alice and Mike wrap up the episode by reviewing several interesting articles in the July 2024 issue of Diabetes Care. Studies highlighted in this segment include: • Daniele et al. β-Cell Function, Incretin Effect, and Glucose Kinetics in Response to a Mixed Meal in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin. https://doi.org/10.2337/dc23-2051 • Spaur et al. Association of Water Arsenic With Incident Diabetes in U.S. Adults: The Multi-Ethnic Study of Atherosclerosis and the Strong Heart Study. https://doi.org/10.2337/dc23-2231    • Zhao et al. Hypoglycemic Response to Dorzagliatin in a Patient With GCK-MODY. https://doi.org/10.2337/dc23-2417     • Fortmann et al. Medical Assistant Health Coaching for Type 2 Diabetes in Primary Care: Results From a Pragmatic Cluster Randomized Controlled Trial. https://doi.org/10.2337/dc23-2487  • Bilal et al. Impaired Awareness of Hypoglycemia in Older Adults With Type 1 Diabetes: A Post Hoc Analysis of the WISDM Study. https://doi.org/10.2337/dc24-0201 • Bratke et al. Ten Years of Improving Glycemic Control in Pediatric Diabetes Care: Data From the Norwegian Childhood Diabetes Registry. https://doi.org/10.2337/dc24-0086      To learn more about Diabetes Care, please visit diabetesjournals.org/care (https://diabetesjournals.org/care) . Interested in submitting cover art to the journal? Please visit https://diabetesjournals.org/care/pages/submit_a_cover_image.
KDBH: Use of Glucose-Lowering Medications in the Management of Type 2 Diabetes
KDBH: Use of Glucose-Lowering Medications in the Management of Type 2 Diabetes

KDBH: Use of Glucose-Lowering Medications in the Management of Type 2 Diabetes

KDBH: Use of Glucose-Lowering Medications in the Management of Type 2 DiabetesWhen you're using glucose lowering medications to manage type 2 diabetes, a person-centered holistic approach is the standard of care for good reason it can prevent complications and optimize quality of life.
RSS